NSRX Nasus Pharma Ltd: institutional ownership and insider trading
10 funds reported holding $7.53M of Nasus Pharma Ltd in their latest 13F filings; in Q2 2026 funds net sold $83.5K, with 4 new positions and 3 funds selling out; over the last 12 months insiders bought $61.8K and sold $0 on the open market.
Famous investors holding NSRX
- Ken Griffin (Citadel Advisors): $77.0K, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $42.7K, 0.0% of the portfolio
Largest institutional holders of NSRX
- BALYASNY ASSET MANAGEMENT L.P. — $3.14M
- Cable Car Capital, LP — $2.16M
- Velan Capital Investment Management LP — $1.26M
- Hudson Bay Capital Management LP — $472K
- Bleichroeder LP — $314K
- CITADEL ADVISORS LLC — $77.0K
- XTX Topco Ltd — $58.2K
- RENAISSANCE TECHNOLOGIES LLC — $42.7K
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $3.50K
- Caitong International Asset Management Co., Ltd — $14
Recent NSRX insider trades
- Jun 17, 2026: Teleman Dan Benjamin bought 6,550 shares ($20.3K)
- Apr 22, 2026: Teleman Dan Benjamin bought 2,900 shares ($10.9K)
- Mar 31, 2026: Teleman Dan Benjamin bought 15,000 shares ($30.6K)
5%+ owners
- BALYASNY ASSET MANAGEMENT L.P.: 10.0% (Schedule 13G/A, filed Aug 14, 2026)
- Funicular Funds, LP: 5.2% (Schedule 13G, filed Apr 7, 2026)